2017-10-04T10:02:30-05:00 2016-12-31 521855942 Tate and Tryon 2021 L Street NW Suite 400 Washington DC 20036 990 2016-01-01 526039142 AMERICAN PHARMACISTS ASSOCIATION FOUNDATION AMER 2026284410 2215 CONSTITUTION AVE NW WASHINGTON DC 20037 Elizabeth Keyes Executive Director 2026284410 2017-10-04 1 Deborah G Kosnett P00290720 2022932200 2017-10-02 216.59.105.135 2017-10-04 10:02:28 ED P DA39A3EE5E6B4B0D3255BFEF95601890AFD80709 6C9B1A35775087DBDB8A6D25ECA509C7F6C27838 2016 2021-01-29 14:40:06Z APHA FOUNDATION Elizabeth Keyes 2215 CONSTITUTION AVE NW WASHINGTON DC 20037 2004249 0 X WWW.APHAFOUNDATION.ORG X 1953 DC The mission of the APhA Foundation is to improve health by inspiring philanthropy, research and innovation that advances pharmacists' patient care services. The APhA Foundation looks to create a new medication use system where patients, pharmacists, physicians and other health care professionals collaborate to dramatically improve the cost effectiveness and quality of patient health outcomes. 11 10 0 50 0 0 928851 1337181 50432 34704 120950 75212 0 10797 1100233 1457894 132315 69599 0 0 915036 551523 0 0 153732 1132498 1072868 2179849 1693990 -1079616 -236096 5723290 5812188 1277496 1435110 4445794 4377078 X The mission of the APhA Foundation is to improve health by inspiring philanthropy, research and innovation that advances pharmacists' patient care services. The APhA Foundation looks to create a new medication use system where patients, pharmacists, physicians and other health care professionals collaborate to dramatically improve the cost effectiveness and quality of patient health outcomes. 0 0 880635 34704 Science and Research - Our research projects establish new models of practice for pharmacists and redefine patients' healthcare experience. We connect each patient to a pharmacist who empowers them to become successful in managing his or her own health. Our work validated that the pharmacists are essential to helping patients achieve better health outcomes. The Foundation research projects include Immunization Registries, Beating Diabetes, Diabetes Patient Credentialing, and Appointment Based Model with Patients of an Accountable Care Organization. 166148 69599 Awards and Grants - to encourage the enhancement of pharmacists' skills and to provide better service to the public in the area of pharmaceutical care. The Foundation has three award programs: 1) Incentive grants - provides seed funding to pharmacists who want to establish or support already existing patient care services within their pharmacy practice. 2) Pinnacle awards - annual recognition program for contributions to healthcare quality through the medication use process. 3) Student scholarship program - recognizes students who help shape the future of the profession. Library and Archives - serves the information needs of the APhA and APhA Foundation staff, pharmacists, students, researchers, government agencies, reporters and consumers worldwide via a variety of journals and resources and encourages knowledge asset sharing. The library strives to provide access to resources promoting the pharmacy profession and innovative practices. 1046783 1 1 0 0 0 0 0 1 0 1 1 0 0 0 1 0 1 0 0 0 0 0 0 0 1 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 16 0 1 0 0 0 0 0 0 1 1 0 0 0 0 X 11 10 0 0 1 0 1 1 0 1 1 0 0 1 1 1 1 1 1 1 0 0 AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY X AMERICAN PHARMACISTS ASSOCIATION 2026284410 2215 CONSTITUTION AVE NW WASHINGTON DC 20037 Leonard Edloe pRESIDENT 2.00 X X 0 0 0 Troy Trygstad VICE PRESIDENT 2.00 X X 0 0 0 Tim Canning TREasurer 2.00 X X 0 0 0 Thomas E Menighan Secretary 2.00 X X 0 675285 100299 Laura Carpenter DIRECTOR (FROM 3/16) 2.00 X 0 0 0 ED HAMILTON DIRECTor 2.00 X 0 0 0 Jerry Moore Director 2.00 X 0 0 0 Steve Simenson DIRECTOR (FROM 3/16) 2.00 X 0 0 0 Megan Tucker Director 2.00 X 0 0 0 Kelly Valente Director 2.00 X 0 0 0 Eleanor Vogt Director 2.00 X 0 0 0 Kelsea Gallegos Director (thru 3/16) 2.00 X 1000 0 0 Stuart Haines Director (thru 3/16) 2.00 X 0 0 0 Christopher Hocevar Director (thru 3/16) 2.00 X 0 0 0 Bruce Laughrey Treasurer (THRU 3/16) 2.00 X X 0 0 0 Thomas Temple Director (thru 3/16) 2.00 X 0 0 0 ELIZABETH Keyes EXECutive DIRECTOR 3.50 36.50 X 54000 298780 50618 Benjamin Bluml SVP, Research 40.00 X 176533 0 29631 231533 974065 180548 0 0 1 1 0 1337181 1337181 IQ WARE PROGRAM 541900 34704 34704 34704 108549 108549 473905 507242 -33337 -33337 -33337 46547 39113 7434 7434 MISCELLANEOUS INCOME 900099 3363 3363 3363 1457894 34704 0 86009 X 69599 69599 260164 217707 32711 9746 241300 11769 154494 75037 5582 2948 2634 9079 4848 4231 35398 15185 13824 6389 36417 22048 14369 14750 14750 26233 26233 635191 603737 25792 5662 43581 6569 22566 14446 78956 50184 25578 3194 61178 45517 4460 11201 70123 24133 43132 2858 21201 21201 Overhead 73551 73551 Professional dues & sub 13294 2622 5172 5500 Other expense -1607 -239 167 -1535 1693990 1046783 493475 153732 115683 610251 1029539 983384 149599 30831 5657 5314 384331 202942 191286 181389 4231526 4001019 5723290 5812188 182968 375825 814459 476350 280069 582935 1277496 1435110 X 1482568 1363982 1954188 1388258 1009038 1624838 4445794 4377078 5723290 5812188 -236096 167380 0 X X 0 1 X 1 0 X 2034297 2561997 1339709 928851 1337181 8202035 2034297 2561997 1339709 928851 1337181 8202035 4213561 3988474 97476 97522 152382 132691 108549 588620 7434 7434 3363 3363 8801452 144469 0.45320 0.43580 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED X 0 1227804 766849 133558 83960 2044251 1278879 37480 -18415 70140 1227804 1072550 232421 44832 70924 1278879 825498 225573 116763 95284 1072550 697192 206875 4319 82888 825498 0.00000 0.79480 0.20520 0 0 324104 193933 130171 60227 9009 51218 181389 Due to Affiliate 582935 582935 1634790 167380 39112 206492 1428298 26233 3363 29596 1457894 1703506 35749 35749 1667757 26233 26233 1693990 Part III, Line 1a: The Foundation acquired an art collection with an appraised value of approximately $1,300,000 through a donor contribution in a prior year. The collection was received with a permanent donor restriction that the collection cannot and should not be sold. In 2009, the Foundation commissioned two bronze sculptures which depict the roles of pharmacists. The cost to create these sculptures was approximately $120,000. The Foundation's collections are held for public exhibition, are cared for and preserved, and proceeds from de-accessions or insurance recoveries for lost or damaged collection items are designated for future collection acquisitions. Under authoritative guidance issued by the financial accounting standards board (FASB), the foundation has the option of not capitalizing its collections. The Foundation has elected not to capitalize its collections, and accordingly, these collections are not recognized as assets in the accompanying statements of financial position. Purchase of collection items are recognized as reduction in unrestricted net assets in the period of acquisition. Part III, Line 4: The art collection, titled "great moments in pharmacy," provides a pictorial history of pharmacy from early civilization until the 1950's through a series of 40 paintings painted by the artist Robert Thom. The Foundation's articles of incorporation state that "the particular business and objects of said corporation shall be to receive gifts, bequests and devices or property and otherwise to acquire property, real and personal, of whatsoever nature and wheresoever the same may be situate to be used exclusively for the advancement of the science of pharmacy and pharmaceutical education...". The display of this collection furthers the Foundation's educational purposes as it is available to all visitors to the buildings. Reproduction rights to the images have been granted for use in text books and other scholarly books. Part V, Line 4: The Foundation's permanently restricted net assets are used to generate revenue to support the ongoing management and administration of programs. Part XI, Line 2d - Other Adjustments: reclass event expense to Part VIII 39,112. Part XI, Line 4b - Other Adjustments: reclass royalty refund to part viii 3,363. Part XII, Line 2d - Other Adjustments: reclass event expense to Part VIII 39,112. reclass royalty refund to part viii -3,363. mix, mingle and margarita 15960 15960 1445 12586 wine tasting & auction 22532 22532 1620 458 15584 463 1 8055 8055 450 6507 46547 46547 1620 1903 28620 6970 39113 7434 1 Honorarium and Awards 7 14099 Incentive Grants 42 42000 SCholarships 13 13500 Part I, Line 2: Scholarships and/or grants are awarded based on merit. Applications are approved by the board of directors. X X X X 0 1 0 0 0 0 0 0 0 Thomas E Menighan Secretary 0 558930 0 81615 0 34740 0 66179 0 34120 0 775584 0 0 ELIZABETH Keyes EXECutive DIRECTOR 54000 252023 0 28307 0 18450 0 27215 0 23403 54000 349398 0 0 Benjamin Bluml SVP, Research 175243 0 0 0 1290 0 9011 0 20620 0 206164 0 0 0 Part I, Line 4b Elizabeth Keyes, executive director, PARTICIPATED IN A NONQUALIFIED RETIREMENT PLAN. there were No contributions made to the plan or payments received from the plan during 2016. FORM 990, PART VII, SECTION A, LINE 5: ELIZABETH KEYES RECEIVED a portion of her COMPENSATION FROM THE AMERICAN PHARMACISTS ASSOCIATION FOUNDATION, BUT RECEIVED MOST OF HER COMPENSATION FROM THE AMERICAN PHARMACISTS ASSOCIATION, AN UNRELATED AFFILIATE, FOR SERVICES THAT SHE RENDERED TO THE FOUNDATION AS interim EXECUTIVE DIRECTOR. KEYES RECEIVED $298,780 IN TAXABLE COMPENSATION AND $50,618 IN NONTAXABLE COMPENSATION FROM THE AMERICAN PHARMACISTS ASSOCIATION. THOMAS MENIGHAN RECEIVED COMPENSATION FROM THE AMERICAN PHARMACISTS ASSOCIATION, AN UNRELATED AFFILIATE. MENIGHAN RECEIVED $675,285 IN TAXABLE COMPENSATION AND $100,299 IN NONTAXABLE COMPENSATION FROM THE AMERICAN PHARMACISTS ASSOCIATION. Form 990, Part VI, Section A, line 4 THE BYLAWS WERE AMENDED SO THAT THE DEFITION OF A MEMBER NO LONGER INCLUDES "Anyone making a minimum annual contribution, the amount to be fixed by the Board of Directors." THE BYLAWS WERE AMENDED TO CHANGE THE FOUNDATION'S BOARD OF DIRECTORS FROM A BODY OF up to 15 members (CONSISTING OF seven board members elected by the foundation's members, up to seven board members appointed by the Foundation board, and the Secretary of the Foundation) to A BODY CONSISTING OF the Secretary of the Corporation AND up to SIX members who are appointed by the Board of Trustees of the American Pharmacists Association. THE CHANGE IN BOARD STRUCTURE WILL BE PHASED IN OVER SEVERAL YEARS BEGINNING WITH 2017 INSTALLATION OF DIRECTORS. THE BYLAWS WERE AMENDED TO STATE THAT VACANCIES IN THE FOUNDATION BOARD OF DIRECTORS SHALL be filled by appointment by the Board of Trustees of the American Pharmacists Association and any Director so appointed shall serve the remainder of the departed Director's term. Form 990, Part VI, Section A, line 6 The members of the Foundation are the Board of Directors of the Foundation and the members of the Board of Trustees of the American Pharmacists Association. Form 990, Part VI, Section A, line 7a THE FOUNDATION'S BOARD SHALL BE APPOINTED BY The members of the Board of Trustees of the American Pharmacists Association. Form 990, Part VI, Section B, line 11b The board of directors reviews the form 990 before it is filed. Form 990, Part VI, Section B, line 12c The conflict of interest policy is reviewed and signed by all the board of directors annually. The Foundation executive director reviews any business transactions (compensation/services rendered) with board members and this information, if any, is disclosed to the foundation's legal counsel. Legal counsel discloses this information during the executive session review of the board of directors meetings. Form 990, Part VI, Section B, line 15a Top Management Official: The Foundation Board of Directors approves the top management official's employment contract. The compensation in the employment contract was determined through comparability analysis conducted by an independent consultant. OTHER OFFICERS AND KEY EMPLOYEES: COMPENSATION IS DETERMINED THROUGH A YEARLY COMPARABILITY ANALYSIS CONDUCTED BY AN INDEPENDENT CONSULTANT (OR IN THOSE INSTANCES WHEN VACANCIES OCCUR). COMPENSATION INCREASES ARE APPROVED BY THE FOUNDATION CEO. Form 990, Part VI, Section C, line 19 THE ORGANIZATION MAKES ITS ARTICLES OF INCORPORATION, BYLAWS, CONFLICT OF INTEREST POLICY, AND AUDITED FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. Form 990, Part IX, line 11g Consulting Fees: Program service expenses 1,707. Management and general expenses 300. Fundraising expenses 200. Total expenses 2,207. Professional Fees: Program service expenses 290,912. Management and general expenses 4,942. Fundraising expenses 212. Total expenses 296,066. OUTSOURCED SERVICES: Program service expenses 306,836. Management and general expenses 0. Fundraising expenses 0. Total expenses 306,836. WRITERS & EDITORS: Program service expenses 400. Management and general expenses 1,500. Fundraising expenses 0. Total expenses 1,900. LICENSE FEES: Program service expenses 1,606. Management and general expenses 0. Fundraising expenses 0. Total expenses 1,606. HOSTING FEES: Program service expenses 2,276. Management and general expenses 19,050. Fundraising expenses 5,250. Total expenses 26,576. Form 990, Part XII, Line 2C Oversight of audit has not changed from prior year.